Janice Chu 朱嘉仪

Janice's practice focuses on IPOs and listings in Hong Kong, the PRC and the United States. She also advises on a broad range of corporate finance transactions, including Hong Kong and US SPAC listings, de-SPAC transactions, privatisations, takeovers, pre-IPO investments, mergers and acquisitions, private equity and general corporate matters.

Background and experience

Janice's practice focuses on IPOs and listings in Hong Kong, the PRC and the United States. She also advises on a broad range of corporate finance transactions, including Hong Kong and US SPAC listings, de-SPAC transactions, privatisations, takeovers, pre-IPO investments, mergers and acquisitions, private equity and general corporate matters.

Before joining Ogier, Janice worked as an associate in Paul Hastings, where she focused on capital market transactions, including advising on Hong Kong IPOs, takeovers, mergers and acquisitions, and other general corporate matters.

Janice is fluent in Cantonese, English and Mandarin.

Recent representative transactions:

• Xiezhong International Holdings Limited on its US$31.3 million privatisation and delisting from the HKSE
• China Youran Dairy Group (SEHK:9858) on its HK$3.44 billion Hong Kong IPO
• Modern Chinese Medicine Group Co. Ltd. (SEHK:1641) on its Hong Kong IPO
• Geely Automobile Holdings Ltd (SEHK: 0175) on its US$3 billion secondary listing on Shanghai's STAR stock exchange
• China New Energy Limited (SEHK: 1156) on its delisting from AIM of LSE and and subsequent Hong Kong IPO
• InnoCare Pharma Limited on its HK$2.24 billion Hong Kong IPO
• CSSC (Hong Kong) Shipping Company Limited (SEHK:3877) on its HK$2.2 billion Hong Kong IPO

Admitted in:
2023 – England and Wales
2017 - Hong Kong (non-practising)

Education:

• PCLL, The University of Hong Kong
• LLB, The University of Hong Kong
• BSocSc (Government & Laws), The University of Hong Kong

Profile (Simplified Chinese)

朱嘉仪律师专注于香港、中国境内和美国的上市及首次公开募股业务。朱律师的执业领域涵盖广泛的公司融资交易，包括香港及美国SPAC上市、de-SPAC交易、私有化、上市公司收购、上市前融资、合并和收购、私募股权和一般的公司事务。

背景和经验

在加入本所之前，朱律师曾是普衡律师事务所的律师，专注于资本市场交易，包括就香港首次公开募股、收购、并购和其他一般公司事务提供法律意见。

朱律师会流利的广东话、英文和普通话。

近期代表性交易：

• 协众国际控股有限公司2.423 亿港元的私有化并从香港联交所退市

• 中国优然牧业集团有限公司（港交所：9858）筹集34.4亿港元的香港上市

• 现代中药集团有限公司（港交所：1641）的香港上市

• 吉利汽车控股有限公司（港交所：0175）在上海科创板筹集 30 亿美元的二次上市

• 中科天元(China New Energy Limited) （港交所：1156）从伦敦证券交易所的另类投资市场（AIM）退市 及随后的香港上市

• InnoCare Pharma Limited筹集22.4亿港元的香港上市

• 中国船舶（香港）航运租赁有限公司（港交所：3877）筹集22亿港元的香港上市

专业资格

2023年 - 英格兰和威尔斯
2017 – 香港 (非执业中)

教育背景

• 法律专业证书，香港大学

• 法学学士，香港大学

• 社会科学学士(政治学与法学) ，香港大学